Compare AFYA & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AFYA | PLSE |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2019 | 2015 |
| Metric | AFYA | PLSE |
|---|---|---|
| Price | $15.94 | $23.44 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 1 |
| Target Price | $17.00 | ★ $22.00 |
| AVG Volume (30 Days) | 109.9K | ★ 221.9K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.36% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.43 | $840.00 |
| Revenue Next Year | $7.15 | $287.54 |
| P/E Ratio | $9.30 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.00 | $12.56 |
| 52 Week High | $19.76 | $26.30 |
| Indicator | AFYA | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 66.99 | 62.61 |
| Support Level | $14.02 | $13.62 |
| Resistance Level | $15.88 | $26.30 |
| Average True Range (ATR) | 0.46 | 1.55 |
| MACD | 0.06 | 0.23 |
| Stochastic Oscillator | 83.51 | 97.26 |
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.